MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-02-2023
NuVasive Total Liabilities 2011-2026 | NUVA
Annual Total Liabilities NuVasive
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 970 M | 873 M | 840 M | 870 M | 587 M | 695 M | 575 M | 626 M | 619 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 970 M | 575 M | 740 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B |  USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
82.4 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
69.7 M | $ 12.67 | 3.51 % | $ 359 M | USA |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
126 M | $ 7.75 | -1.77 % | $ 1.16 B | USA |
 |
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
45.2 M | $ 4.32 | 2.86 % | $ 162 M |  France |
 |
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.05 | 1.94 % | $ 17.8 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.02 M | $ 1.91 | -6.62 % | $ 42.1 M | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.49 | -0.99 % | $ 30.5 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
162 M | $ 17.17 | -3.59 % | $ 403 M | USA |
 |
LENSAR
LNSR
|
83.7 M | $ 5.8 | -3.33 % | $ 69.4 M | USA |
 |
Delcath Systems
DCTH
|
12.4 M | $ 10.78 | -1.55 % | $ 386 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Pulmonx Corporation
LUNG
|
75.2 M | $ 1.65 | -1.79 % | $ 67.1 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
LivaNova PLC
LIVN
|
1.41 B | $ 73.8 | 1.04 % | $ 4.03 B |  Britain |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
Myomo
MYO
|
27.2 M | $ 1.09 | - | $ 45.6 M | USA |
 |
MiMedx Group
MDXG
|
86.1 M | $ 3.68 | 0.27 % | $ 544 M | USA |
 |
Electromed
ELMD
|
10.6 M | $ 37.72 | -4.0 % | $ 319 M | USA |
 |
Orthofix Medical
OFIX
|
401 M | $ 9.27 | -2.32 % | $ 367 M |  Curacao |
 |
Butterfly Network
BFLY
|
101 M | $ 4.55 | -1.3 % | $ 1.12 B | USA |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Profound Medical Corp.
PROF
|
11 M | $ 6.81 | -1.3 % | $ 206 M | Canada |
 |
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
730 M | $ 81.88 | -0.69 % | $ 11.1 B | USA |
 |
Insulet Corporation
PODD
|
1.68 B | $ 144.94 | 1.61 % | $ 10.2 B | USA |
 |
Sintx Technologies
SINT
|
6.58 M | $ 2.24 | 1.82 % | $ 6.21 M | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | $ 35.7 | 0.51 % | $ 1.11 B | USA |
 |
Inspire Medical Systems
INSP
|
126 M | $ 41.36 | -3.97 % | $ 1.21 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.66 B | $ 89.38 | -0.74 % | $ 3.1 B | USA |
 |
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 86.47 | 0.59 % | $ 50.6 B | USA |
 |
TransMedics Group
TMDX
|
595 M | $ 67.2 | -0.93 % | $ 2.28 B | USA |